These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 25937192)
21. Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. Lurz P; Luecke C; Eitel I; Föhrenbach F; Frank C; Grothoff M; de Waha S; Rommel KP; Lurz JA; Klingel K; Kandolf R; Schuler G; Thiele H; Gutberlet M J Am Coll Cardiol; 2016 Apr; 67(15):1800-1811. PubMed ID: 27081020 [TBL] [Abstract][Full Text] [Related]
22. Assessment of Diffuse Ventricular Myocardial Fibrosis Using Native T1 in Children With Repaired Tetralogy of Fallot. Yim D; Riesenkampff E; Caro-Dominguez P; Yoo SJ; Seed M; Grosse-Wortmann L Circ Cardiovasc Imaging; 2017 Mar; 10(3):. PubMed ID: 28292861 [TBL] [Abstract][Full Text] [Related]
23. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease. Ngu PJ; Butler M; Pham A; Roberts SK; Taylor AJ Int J Cardiovasc Imaging; 2016 Apr; 32(4):629-36. PubMed ID: 26667447 [TBL] [Abstract][Full Text] [Related]
25. Characterization of acute myocardial infarction by magnetic resonance imaging. Mather AN; Greenwood JP; Plein S JACC Cardiovasc Imaging; 2009 Sep; 2(9):1141-3. PubMed ID: 19761995 [No Abstract] [Full Text] [Related]
26. T1 mapping in cardiac amyloidosis: can we get there from here? Ruberg FL JACC Cardiovasc Imaging; 2013 Apr; 6(4):498-500. PubMed ID: 23498671 [No Abstract] [Full Text] [Related]
27. T1 Mapping in Characterizing Myocardial Disease: A Comprehensive Review. Puntmann VO; Peker E; Chandrashekhar Y; Nagel E Circ Res; 2016 Jul; 119(2):277-99. PubMed ID: 27390332 [TBL] [Abstract][Full Text] [Related]
28. Detecting diffuse myocardial fibrosis with CMR: the future has only just begun. Karamitsos TD; Neubauer S JACC Cardiovasc Imaging; 2013 Jun; 6(6):684-6. PubMed ID: 23764096 [No Abstract] [Full Text] [Related]
29. T1-mapping provides superior diagnostic accuracy than late gadolinium enhancement imaging in patients with acute myocarditis. Spartalis M; Tzatzaki E; Doulamis IP; Spartalis E Int J Cardiol; 2018 Apr; 257():341. PubMed ID: 29506727 [No Abstract] [Full Text] [Related]
30. Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study. aus dem Siepen F; Buss SJ; Andre F; Seitz S; Giannitsis E; Steen H; Katus HA; Kristen AV Clin Res Cardiol; 2015 Aug; 104(8):640-7. PubMed ID: 25855392 [TBL] [Abstract][Full Text] [Related]
31. Changes of late gadolinium enhancement extension compared with native T1 mapping early after acute myocarditis. Ammirati E; Sormani P; Moroni F; Camici PG; Pedrotti P Int J Cardiol; 2018 Apr; 257():227. PubMed ID: 29506700 [No Abstract] [Full Text] [Related]
32. Arrhythmia insensitive rapid cardiac T1 mapping pulse sequence. Fitts M; Breton E; Kholmovski EG; Dosdall DJ; Vijayakumar S; Hong KP; Ranjan R; Marrouche NF; Axel L; Kim D Magn Reson Med; 2013 Nov; 70(5):1274-82. PubMed ID: 23280998 [TBL] [Abstract][Full Text] [Related]
33. Magnetic Resonance Characterization of Cardiac Adaptation and Myocardial Fibrosis in Pulmonary Hypertension Secondary to Systemic-To-Pulmonary Shunt. Pereda D; García-Lunar I; Sierra F; Sánchez-Quintana D; Santiago E; Ballesteros C; Encalada JF; Sánchez-González J; Fuster V; Ibáñez B; García-Álvarez A Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27601365 [TBL] [Abstract][Full Text] [Related]
35. Usefulness of cardiac magnetic resonance imaging in the diagnosis of cardiac myocarditis revealed by complete atrioventricular block. Chauveau S; Girerd N; Chevalier P Arch Cardiovasc Dis; 2014 Apr; 107(4):274-5. PubMed ID: 23791597 [No Abstract] [Full Text] [Related]
36. Performance of native and contrast-enhanced T1 mapping to detect myocardial damage in patients with suspected myocarditis: a head-to-head comparison of different cardiovascular magnetic resonance techniques. Nadjiri J; Nieberler H; Hendrich E; Greiser A; Will A; Martinoff S; Hadamitzky M Int J Cardiovasc Imaging; 2017 Apr; 33(4):539-547. PubMed ID: 27878700 [TBL] [Abstract][Full Text] [Related]
37. T1 mapping for diffuse myocardial fibrosis: a key biomarker in cardiac disease? Moon JC; Treibel TA; Schelbert EB J Am Coll Cardiol; 2013 Oct; 62(14):1288-1289. PubMed ID: 23871882 [No Abstract] [Full Text] [Related]
38. Magnetic resonance imaging for characterizing myocardial diseases. Saeed M; Liu H; Liang CH; Wilson MW Int J Cardiovasc Imaging; 2017 Sep; 33(9):1395-1414. PubMed ID: 28364177 [TBL] [Abstract][Full Text] [Related]
39. Myocardial Mapping With Cardiac Magnetic Resonance: The Diagnostic Value of Novel Sequences. Sanz J; LaRocca G; Mirelis JG Rev Esp Cardiol (Engl Ed); 2016 Sep; 69(9):849-61. PubMed ID: 27450946 [TBL] [Abstract][Full Text] [Related]
40. Role of Cardiac MR Imaging in Cardiomyopathies. Kramer CM J Nucl Med; 2015 Jun; 56 Suppl 4(0 4):39S-45S. PubMed ID: 26033902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]